{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T15:26:27Z","timestamp":1764948387257,"version":"3.46.0"},"reference-count":23,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"abstract":"<jats:p>Regarding cardiovascular (CV) risk, patients with type 1 diabetes mellitus (T1D) are a heterogeneous population with CV risk ranging from low to very high. For personalized prevention strategies, screening for subclinical atherosclerosis may be of clinical significance. However, more data is needed. Our study aimed to describe the prevalence of prognostically significant findings on invasive coronary artery examination in patients with subclinical atherosclerosis determined by non-invasive examination of the carotid and coronary arteries. Patients with T1D for at least 10 years, without a prior history of atherosclerotic CV disease or target organ damage, followed at a large tertiary hospital were enrolled. Non-invasive examinations included carotid ultrasound for carotid plaque detection and a CT for coronary artery calcium (CAC) score evaluation. Patients with the presence of \u22652 carotid plaques and\/or CAC score of \u2265400 were classified as very high risk (VHR). These VHR patients were subsequently evaluated using invasive coronary angiography (ICA) for the presence of obstructive coronary artery disease (CAD) and intracoronary optical coherence tomography (OCT) for the presence of thin-cap fibroatheroma (TCFA) and very high-risk plaque. Moreover, hemodynamic stenosis relevance was assessed by the vessel fraction flow ratio (vFFR). Sixty-two T1D patients aged 50.1\u00b112.7 years, 53 % women were enrolled. The criteria of VHR were fulfilled in 12\/62 (19.4 %) patients, of which 6 (50 % of VHR) had both CAC\u2265400 and at least 2 atherosclerotic plaques in the carotid arteries, one patient (8 % of the VHR) fulfilled only the CAC criteria and 5 (42 % of VHR) only the carotid criteria. The median CAC score of the VHR group was 606.3 (175.3-1515) and the mean number of carotid plaques was 2.75\u00b11.06. ICA showed obstructive CAD in 5\/12 (41.7 %) patients, and 3\/12 (25 %) had vFFR-positive lesions. Using OCT, TCFA was present in 7\/12 (58.3 %) and a very high-risk plaque in 4\/12 (33.3 %) patients. Among asymptomatic patients with T1D, the combination of coronary artery calcium score and carotid ultrasound identifies a very high-risk group, in which 58.3 % of patients had a thin-cap fibroatheroma and 33.3 % of patients had a very high-risk plaque. Patients identified by these non-invasive techniques may benefit from intensive risk factors management.<\/jats:p>","DOI":"10.33549\/physiolres.935614","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:09:11Z","timestamp":1764778151000},"page":"767","source":"Crossref","is-referenced-by-count":0,"title":["Risk Stratification and Coronary Optical Coherence Tomography Findings in Asymptomatic Patients With Type 1 Diabetes Mellitus"],"prefix":"10.33549","author":[{"given":"R","family":"Roland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Dubsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Wohlfahrt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Marhefkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Sonka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Karmazin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Haluzik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Kautzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Pazdernik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"19169","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"1. Emerging Risk Factors Collaboration, Sarwar N, Gao P, Kondapally Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010;375:2215-2222. https:\/\/doi.org\/10.1016\/S0140-6736(10)60484-9 DOI: 10.1016\/S0140-6736(10)60484-9","DOI":"10.1016\/S0140-6736(10)60484-9"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2. Kedhi E, Berta B, Roleder T, Hermanides RS, Fabris E, IJsselmuiden AJJ, Kauer F, et al. Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial. Eur Heart J 2021;42:4671-4679. https:\/\/doi.org\/10.1093\/eurheartj\/ehab433 DOI: 10.1093\/eurheartj\/ehab433","DOI":"10.1093\/eurheartj\/ehab433"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3. Park SJ, Ahn JM, Kang DY, Yun S-C, Ahn Y-K, Kim W-J, Nam C-W, et al. Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial. Lancet 2024;403:1753-1765. https:\/\/doi.org\/10.1016\/S0140-6736(24)00413-6 DOI: 10.1016\/S0140-6736(24)00413-6","DOI":"10.1016\/S0140-6736(24)00413-6"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, Benetos A, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021;42:3227-3337. https:\/\/doi.org\/10.1093\/eurheartj\/ehab484 DOI: 10.1093\/eurheartj\/ehab484","DOI":"10.1093\/eurheartj\/ehab484"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"5. Johri AM, Nambi V, Naqvi TZ, Feinstein SB, Kim ESH, Park MM, Becher H, Sillesen H. Recommendations for the Assessment of Carotid Arterial Plaque by Ultrasound for the Characterization of Atherosclerosis and Evaluation of Cardiovascular Risk: From the American Society of Echocardiography. J Am Soc Echocardiogr 2020;33:917-933. https:\/\/doi.org\/10.1016\/j.echo.2020.04.021 DOI: 10.1016\/j.echo.2020.04.021","DOI":"10.1016\/j.echo.2020.04.021"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-832. https:\/\/doi.org\/10.1016\/0735-1097(90)90282-T DOI: 10.1016\/0735-1097(90)90282-T","DOI":"10.1016\/0735-1097(90)90282-T"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"7. Masdjedi K, Tanaka N, Van Belle E, Porouchani S, Linke A, Woitek FJ, Bartorelli AL, et al. Vessel fractional flow reserve (vFFR) for the assessment of stenosis severity: the FAST II study. EuroIntervention 2022;17:1498-1505. https:\/\/doi.org\/10.4244\/EIJ-D-21-00471 DOI: 10.4244\/EIJ-D-21-00471","DOI":"10.4244\/EIJ-D-21-00471"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"8. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, Bouma B, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol 2012;59:1058-1072. https:\/\/doi.org\/10.1016\/j.jacc.2011.09.079 DOI: 10.1016\/j.jacc.2011.09.079","DOI":"10.1016\/j.jacc.2011.09.079"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"9. Prati F, Romagnoli E, Gatto L, La Manna A, Burzotta F, Ozaki Y, Marco V, et al. Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study. Eur Heart J 2020;41:383-391. https:\/\/doi.org\/10.1093\/eurheartj\/ehz520 DOI: 10.1093\/eurheartj\/ehz520","DOI":"10.1093\/eurheartj\/ehz520"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"10. Haffner SM, Lehto S, R\u00f6nnemaa T, Py\u00f6r\u00e4l\u00e4 K, Laakso M. Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction. New Engl J Med 1998;339:229-234. https:\/\/doi.org\/10.1056\/NEJM199807233390404 DOI: 10.1056\/NEJM199807233390404","DOI":"10.1056\/NEJM199807233390404"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"11. Zhao Y, Malik S, Budoff MJ, Correa A, Ashley KE, Selvin E, Watson KE, Wong ND. Identification and Predictors for Cardiovascular Disease Risk Equivalents among Adults With Diabetes Mellitus. Diabetes Care 2021:dc210431. https:\/\/doi.org\/10.2337\/dc21-0431 DOI: 10.2337\/figshare.14807256.v1","DOI":"10.2337\/figshare.14807256.v1"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"12. Marx N, Federici M, Sch\u00fctt K, M\u00fcller-Wieland D, Ajjan RA, Antunes MJ, Christodorescu RM, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC). Eur Heart J 2023;44:4043-4140. https:\/\/doi.org\/10.1093\/eurheartj\/ehad192 DOI: 10.1093\/eurheartj\/ehad774","DOI":"10.1093\/eurheartj\/ehad774"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"13. Shaw LJ, Min JK, Budoff M, Gransar H, Rozanski A, Hayes SW, Friedman JD, et al. Induced cardiovascular procedural costs and resource consumption patterns after coronary artery calcium screening: results from the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) study. J Am Coll Cardiol 2009;54:1258-1267. https:\/\/doi.org\/10.1016\/j.jacc.2009.07.018 DOI: 10.1016\/j.jacc.2009.07.018","DOI":"10.1016\/j.jacc.2009.07.018"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"14. Lehker A, Mukherjee D. Coronary Calcium Risk Score and Cardiovascular Risk. Curr Vasc Pharmacol 2021;19:280-284. https:\/\/doi.org\/10.2174\/1570161118666200403143518 DOI: 10.2174\/1570161118666200403143518","DOI":"10.2174\/1570161118666200403143518"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"15. Budoff MJ, Kinninger A, Gransar H, Achenbach S, Al-Mallah M, Bax JJ, Berman DS, et al. When Does a Calcium Score Equate to Secondary Prevention?: Insights From the Multinational CONFIRM Registry. JACC Cardiovasc Imaging 2023;16:1181-1189. https:\/\/doi.org\/10.1016\/j.jcmg.2023.03.008 DOI: 10.1016\/j.jcmg.2023.03.008","DOI":"10.1016\/j.jcmg.2023.03.008"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"16. Polak JF, Szklo M, Kronmal RA, Burke GL, Shea S, Zavodni AEH, O'Leary DH. The value of carotid artery plaque and intima-media thickness for incident cardiovascular disease: the multi-ethnic study of atherosclerosis. J Am Heart Assoc 2013;2:e000087. https:\/\/doi.org\/10.1161\/JAHA.113.000087 DOI: 10.1161\/JAHA.113.000087","DOI":"10.1161\/JAHA.113.000087"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"17. Polak JF, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, D'Agostino RB Sr. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 2011;365:213-221. https:\/\/doi.org\/10.1056\/NEJMoa1012592 DOI: 10.1056\/NEJMoa1012592","DOI":"10.1056\/NEJMoa1012592"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"18. Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Boden WE, Chaitman BR, et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. New Engl J Med 2020;382:1395-1407. https:\/\/doi.org\/10.1056\/NEJMoa1915922 DOI: 10.1056\/NEJMoa1915922","DOI":"10.1056\/NEJMoa1915922"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"19. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006;47(8 Suppl):C13-C18. https:\/\/doi.org\/10.1016\/j.jacc.2005.10.065 DOI: 10.1016\/j.jacc.2005.10.065","DOI":"10.1016\/j.jacc.2005.10.065"},{"key":"ref19","unstructured":"20. Kataoka Y, Puri R, Hammadah M, Duggal B, Uno K, Kapadia SR, Tuzcu EM, et al. Spotty calcification and plaque vulnerability in vivo: frequency-domain optical coherence tomography analysis. Cardiovasc Diagn Ther 2014;4:460-469. https:\/\/doi.org\/10.3978\/j.issn.2223-3652.2014.11.06"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"21. Dai J, Tian J, Hou J, Xing L, Liu S, Ma L, Yu H, et al. Association between cholesterol crystals and culprit lesion vulnerability in patients with acute coronary syndrome: An optical coherence tomography study. Atherosclerosis 2016;247:111-117. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.02.010 DOI: 10.1016\/j.atherosclerosis.2016.02.010","DOI":"10.1016\/j.atherosclerosis.2016.02.010"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"22. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, et al. 2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019;140:e596-e646. https:\/\/doi.org\/10.1161\/CIR.0000000000000678. Published correction appears in Circulation 2019;140:e649-e650. https:\/\/doi.org\/10.1161\/CIR.0000000000000725 DOI: 10.1161\/CIR.0000000000000725","DOI":"10.1161\/CIR.0000000000000725"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"23. Miedema MD, Duprez DA, Misialek JR, Blaha MJ, Nasir K, Silverman MG, Blankstein R, et al. Use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the multi-ethnic study of atherosclerosis. Circ Cardiovasc Qual Outcomes 2014;7:453-460. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.113.000690 DOI: 10.1161\/CIRCOUTCOMES.113.000690","DOI":"10.1161\/CIRCOUTCOMES.113.000690"}],"container-title":["Physiological Research"],"original-title":[],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T15:22:03Z","timestamp":1764948123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2025\/74_767.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":23,"URL":"https:\/\/doi.org\/10.33549\/physiolres.935614","relation":{},"ISSN":["0862-8408","1802-9973"],"issn-type":[{"type":"print","value":"0862-8408"},{"type":"electronic","value":"1802-9973"}],"subject":[],"published":{"date-parts":[[2025,10,31]]}}}